欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7110/001
药品名称Azelastine hydrochloride / Fluticasone propionate Teva
活性成分
    • azelastine hydrochloride 137.0 µg
    • fluticasone propionate 50.0 µg
剂型Nasal spray, suspension
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Azelastin/Fluticason-ratiopharm 137 Mikrogramm/50 Mikrogramm pro Sprühstoß Nasenspray, Suspension
互认成员国 - 产品名称
    • Latvia (LV)
    • Netherlands (NL)
    • Lithuania (LT)
      -
    • Iceland (IS)
    • Estonia (EE)
    • Ireland (IE)
    • Austria (AT)
    • Bulgaria (BG)
      Duonase
    • France (FR)
    • Czechia (CZ)
      Azelastin/flutikason TEVA
    • Spain (ES)
    • Slovakia (SK)
    • Portugal (PT)
    • Croatia (HR)
    • Sweden (SE)
    • Norway (NO)
      Azelastine hydrochloride/FluticasoneTeva
    • Finland (FI)
    • Poland (PL)
      Duonase
    • Denmark (DK)
许可日期2023/08/31
最近更新日期2023/10/12
药物ATC编码
    • R01AD58 fluticasone, combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase